New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 9, Pages 2671
Publisher
MDPI AG
Online
2021-05-02
DOI
10.3390/molecules26092671
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance
- (2021) Beata Kowalska-Krochmal et al. Pathogens
- Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations
- (2020) Nermin E. Eleraky et al. Pharmaceutics
- Multidrug resistant infections in the COVID-19 era, a framework for considering the potential impact
- (2020) Daniele Donà et al. JOURNAL OF HOSPITAL INFECTION
- Zoliflodacin: An Oral Spiropyrimidinetrione Antibiotic for the Treatment of Neisseria gonorrheae, Including Multi-Drug-Resistant Isolates
- (2020) Patricia A. Bradford et al. ACS Infectious Diseases
- Eravacycline: A Review in Complicated Intra-Abdominal Infections
- (2019) Lesley J. Scott DRUGS
- Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
- (2019) George G. Zhanel et al. DRUGS
- Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine
- (2019) Jiali Zhai et al. ACS Nano
- Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm
- (2019) Pengyu Li et al. JOURNAL OF CONTROLLED RELEASE
- Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin
- (2019) Takafumi Sato et al. CLINICAL INFECTIOUS DISEASES
- Hybrid Ofloxacin/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties
- (2019) B. Rodenak-Kladniew et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Evaluation of co-delivery of colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model
- (2019) Guihong Chai et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates
- (2018) David R. Snydman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
- (2018) L Clifford McDonald et al. CLINICAL INFECTIOUS DISEASES
- Non-lamellar lyotropic liquid crystalline nanoparticles enhance the antibacterial effects of rifampicin against Staphylococcus aureus
- (2018) Nhiem Tran et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Lack of phototoxicity potential with delafloxacin in healthy male and female subjects: comparison to lomefloxacin
- (2018) R. S. Dawe et al. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824)
- (2018) Rafael Baptista et al. Scientific Reports
- Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae
- (2018) Lindsay Petty et al. Infection and Drug Resistance
- Safety of Delafloxacin: Focus on Adverse Events of Special Interest
- (2018) Thomas Lodise et al. Open Forum Infectious Diseases
- Single-Dose Pharmacokinetics, Excretion, and Metabolism of Zoliflodacin, a Novel Spiropyrimidinetrione Antibiotic, in Healthy Volunteers
- (2018) John O’Donnell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Loading and releasing ciprofloxacin in photoactivatable liposomes
- (2018) Sanjana Ghosh et al. BIOCHEMICAL ENGINEERING JOURNAL
- In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015
- (2018) James A. Karlowsky et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Stability of cefiderocol against clinically significant broad-spectrum oxacillinases
- (2018) Laurent Poirel et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Biosurfactant coated silver and iron oxide nanoparticles with enhanced anti-biofilm and anti-adhesive properties
- (2018) Hafiza Faiza Khalid et al. JOURNAL OF HAZARDOUS MATERIALS
- Profile of a Novel Anionic Fluoroquinolone—Delafloxacin
- (2018) Paul M Tulkens et al. CLINICAL INFECTIOUS DISEASES
- In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE)
- (2017) Yunliang Zhang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections
- (2017) Massimo Sartelli et al. World Journal of Emergency Surgery
- Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
- (2016) George G. Zhanel et al. DRUGS
- Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence
- (2016) Emanuele Pontali et al. EUROPEAN RESPIRATORY JOURNAL
- Access to effective antimicrobials: a worldwide challenge
- (2016) Ramanan Laxminarayan et al. LANCET
- The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase
- (2016) Wafi Siala et al. Nature Communications
- A Thorough QT Study To Evaluate the Effects of Therapeutic and Supratherapeutic Doses of Delafloxacin on Cardiac Repolarization
- (2015) Jeffrey S. Litwin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and Healthcare Burden of Multiple Recurrences ofClostridium difficileInfection
- (2015) Caroline Sheitoyan-Pesant et al. CLINICAL INFECTIOUS DISEASES
- Tetracycline antibiotics and resistance mechanisms
- (2014) Fabian Nguyen et al. BIOLOGICAL CHEMISTRY
- Dissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation–lyophilization–homogenization method
- (2014) Boontida Morakul et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection
- (2013) S.B. Debast et al. CLINICAL MICROBIOLOGY AND INFECTION
- Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa
- (2013) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Burden of Clostridium difficile on the Healthcare System
- (2012) Erik R. Dubberke et al. CLINICAL INFECTIOUS DISEASES
- Challenges of Antibacterial Discovery
- (2011) L. L. Silver CLINICAL MICROBIOLOGY REVIEWS
- Nitroimidazoles for the treatment of TB: past, present and future
- (2011) Tathagata Mukherjee et al. Future Medicinal Chemistry
- Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- ACHN-490, a Neoglycoside with Potent In Vitro Activity Against Multidrug-Resistant Klebsiella pneumoniae Isolates
- (2009) A. Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Staphylococcus aureus: new evidence for intracellular persistence
- (2009) Christian Garzoni et al. TRENDS IN MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search